Meta-analysis: Ertapenem for complicated intra-abdominal infections

Alimentary Pharmacology and Therapeutics

Volumn 27, Issue 10, 2008, Pages 919-931

  Falagas, M E ^a,b,c   Peppas, G ^a,c   Makris, G C ^a   Karageorgopoulos, D E ^a   Matthaiou, D K ^a  

^a ALFA INSTITUTE OF BIOMEDICAL SCIENCES AIBS   (Greece)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c HENRY DUNANT HOSPITAL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CEFTRIAXONE; CIPROFLOXACIN; ERTAPENEM; METRONIDAZOLE; PIPERACILLIN PLUS TAZOBACTAM; TEICOPLANIN; TIMENTIN; VANCOMYCIN;

ABDOMINAL INFECTION; ADVERSE OUTCOME; ANTIMICROBIAL THERAPY; ARTICLE; CLINICAL TRIAL; COCHRANE LIBRARY; COMPARATIVE STUDY; CONFIDENCE INTERVAL; DIARRHEA; DISEASE SEVERITY; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG SUBSTITUTION; ENTEROCOCCUS; GASTROINTESTINAL SYMPTOM; GRAM POSITIVE BACTERIUM; HUMAN; INJECTION SITE REACTION; MEDLINE; META ANALYSIS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MORTALITY; NAUSEA; OUTCOME ASSESSMENT; PHLEBITIS; POPULATION RESEARCH; PRIORITY JOURNAL; SYSTEMATIC REVIEW; THROMBOPHLEBITIS; UNSPECIFIED SIDE EFFECT; VOMITING;

ABDOMEN; ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; BETA-LACTAMS; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 42149133723     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2008.03642.x     Document Type: Article

References (37)

1. Zhanel GG, Wiebe R, Dilay L, et al. Comparative review of the carbapenems. Drugs 2007 67 : 1027 52.
2. Solomkin JS, Mazuski JE, Baron EJ, et al. Guidelines for the selection of anti-infective agents for complicated intra-abdominal infections. Clin Infect Dis 2003 37 : 997 1005.
3. Falagas ME, Gorbach SL. Clindamycin and metronidazole. Med Clin North Am 1995 79 : 845 67.
4. Falagas ME, Matthaiou DK, Bliziotis IA. Systematic review: fluoroquinolones for the treatment of intra-abdominal surgical infections. Aliment Pharmacol Ther 2007 25 : 123 31.
5. Matthaiou DK, Peppas G, Bliziotis IA, et al. Ciprofloxacin/metronidazole versus beta-lactam-based treatment of intra-abdominal infections: a meta-analysis of comparative trials. Int J Antimicrob Agents 2006 28 : 159 65.
6. Falagas ME, Matthaiou DK, Karveli EA, et al. Meta-analysis: randomized controlled trials of clindamycin/aminoglycoside vs. beta-lactam monotherapy for the treatment of intra-abdominal infections. Aliment Pharmacol Ther 2007 25 : 537 56.
7. Livermore DM, Carter MW, Bagel S, et al. In vitro activities of ertapenem (MK-0826) against recent clinical bacteria collected in Europe and Australia. Antimicrob Agents Chemother 2001 45 : 1860 7.
8. Fuchs PC, Barry AL, Brown SD. In vitro activities of ertapenem (MK-0826) against clinical bacterial isolates from 11 North American medical centers. Antimicrob Agents Chemother 2001 45 : 1915 8.
9. Zhanel GG, Johanson C, Embil JM, et al. Ertapenem: review of a new carbapenem. Expert Rev Anti Infect Ther 2005 3 : 23 39.
10. Khan KS, Daya S, Jadad A. The importance of quality of primary studies in producing unbiased systematic reviews. Arch Intern Med 1996 156 : 661 6.
11. Moher D, Jadad AR, Tugwell P. Assessing the quality of randomized controlled trials. Current issues and future directions. Int J Technol Assess Health Care 1996 12 : 195 208.
12. Higgins JP, Thompson SG. Controlling the risk of spurious findings from meta-regression. Stat Med 2004 23 : 1663 82.
13. Egger M, Davey SG, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997 315 : 629 34.
14. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959 22 : 719 48.
15. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986 7 : 177 88.
16. Namias N, Solomkin JS, Jensen EH, et al. Randomized, multicenter, double-blind study of efficacy, safety, and tolerability of intravenous ertapenem versus piperacillin/tazobactam in treatment of complicated intra-abdominal infections in hospitalized adults. Surg Infect (Larchmt) 2007 8 : 15 28.
17. Yellin AE, Johnson J, Higareda I, et al. Ertapenem or ticarcillin/clavulanate for the treatment of intra-abdominal infections or acute pelvic infections in pediatric patients. Am J Surg 2007 194 : 367 74.
18. Dela Pena AS, Asperger W, Kockerling F, et al. Efficacy and safety of ertapenem versus piperacillin-tazobactam for the treatment of intra-abdominal infections requiring surgical intervention. J Gastrointest Surg 2006 10 : 567 74.
19. Navarro NS Jr., Campos MI, Alvarado R, et al. Ertapenem versus ceftriaxone and metronidazole as treatment for complicated intra-abdominal infections. Int J Surg 2005 3 : 25 34.
20. Roy S, Higareda I, Angel-Muller E, et al. Ertapenem once a day versus piperacillin-tazobactam every 6 hours for treatment of acute pelvic infections: a prospective, multicenter, randomized, double-blind study. Infect Dis Obstet Gynecol 2003 11 : 27 37.
21. Solomkin JS, Yellin AE, Rotstein OD, et al. Ertapenem versus piperacillin/tazobactam in the treatment of complicated intraabdominal infections: results of a double-blind, randomized comparative phase III trial. Ann Surg 2003 237 : 235 45.
22. Yellin AE, Hassett JM, Fernandez A, et al. Ertapenem monotherapy versus combination therapy with ceftriaxone plus metronidazole for treatment of complicated intra-abdominal infections in adults. Int J Antimicrob Agents 2002 20 : 165 73.
23. Hemsell DL, Solomkin JS, Sweet R, et al. Evaluation of new anti-infective drugs for the treatment of acute pelvic infections in hospitalized women. Infectious Diseases Society of America and the Food and Drug Administration. Clin Infect Dis 1992 15 : S43 52.
24. Gesser RM, McCarroll K, Teppler H, et al. Efficacy of ertapenem in the treatment of serious infections caused by Enterobacteriaceae: analysis of pooled clinical trial data. J Antimicrob Chemother 2003 51 : 1253 60.
25. Solomkin J, Teppler H, Graham DR, et al. Treatment of polymicrobial infections: post hoc analysis of three trials comparing ertapenem and piperacillin-tazobactam. J Antimicrob Chemother 2004 53 (Suppl. 2 ii51 7.
26. Tellado J, Woods GL, Gesser R, et al. Ertapenem versus piperacillin-tazobactam for treatment of mixed anaerobic complicated intra-abdominal, complicated skin and skin structure, and acute pelvic infections. Surg Infect (Larchmt) 2002 3 : 303 14.
27. Teppler H, Meibohm AR, Woods GL. Management of complicated appendicitis and comparison of outcome with other primary sites of intra-abdominal infection: results of a trial comparing ertapenem and piperacillin-tazobactam. J Chemother 2004 16 : 62 9.
28. Yellin AE, Heseltine PN, Berne TV, et al. The role of Pseudomonas species in patients treated with ampicillin and Sulbactam for gangrenous and perforated appendicitis. Surg Gynecol Obstet 1985 161 : 303 7.
29. Wittau M, Wagner E, Kaever V, et al. Intraabdominal tissue concentration of ertapenem. J Antimicrob Chemother 2006 57 : 312 6.
30. Laethem T, De LI, McCrea J, et al. Tissue penetration by ertapenem, a parenteral carbapenem administered once daily, in suction-induced skin blister fluid in healthy young volunteers. Antimicrob Agents Chemother 2003 47 : 1439 42.
31. DiNubile MJ, Chow JW, Satishchandran V, et al. Acquisition of resistant bowel flora during a double-blind randomized clinical trial of ertapenem versus piperacillin-tazobactam therapy for intraabdominal infections. Antimicrob Agents Chemother 2005 49 : 3217 21.
32. Basoli A, Chirletti P, Cirino E, et al. A prospective, double-blind, multicenter, randomized trial comparing ertapenem 3 vs >/=5 days in community-acquired intraabdominal infection. J Gastrointest Surg 2008 12 : 592 600.
33. Falagas ME, Barefoot L, Griffith J, et al. Risk factors leading to clinical failure in the treatment of intra-abdominal or skin/soft tissue infections. Eur J Clin Microbiol Infect Dis 1996 15 : 913 21.
34. No Authors Listed. Efficacy of invanz proven in the treatment of intra-abdominal infections in one of the largest studies yet conducted on surgical patients. Khirurgiia (Sofiia) 2003 59 : 56.
35. Zaǐtsev AA. Carbapenem antibiotic ertapenem in the treatment of extrahospital intraabdominal infections. Khirurgiia (Mosk) 2003 : 51 4.
36. Siempos II, Dimopoulos G, Falagas ME. From the authors. Eur Resp J 2007 30 : 815 6.
37. Pham B, Klassen TP, Lawson ML, Moher D. Language of publication restrictions in systematic reviews gave different results depending on whether the intervention was conventional or complementary. J Clin Epidemiol 2005 58 : 769 76.